Ask AI
S. 3702

Right Rebate Act of 2018

Right Rebate Act of 2018

This bill requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).

Read twice and referred to the Committee on Finance.

Sen. Wyden, Ron [D-OR](D-OR)Sponsor
10 cosponsors8 D2 R
10cosponsors1committees2actions2related bills7subjects
  1. IntroReferral

    Read twice and referred to the Committee on Finance.

    Finance Committee
  2. IntroReferral10000

    Introduced in Senate

Right Rebate Act of 2018 — Informed